- Home
- INTZ vs CING Comparison
INTZ vs CING Comparison
Compare INTZ & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- CING
- Stock Information
- Founded
- INTZ 1983
- CING 2012
- Country
- INTZ United States
- CING United States
- Employees
- INTZ N/A
- CING N/A
- Industry
- INTZ Computer Communications Equipment
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- CING Health Care
- Exchange
- INTZ Nasdaq
- CING Nasdaq
- Market Cap
- INTZ 33.2M
- CING 26.7M
- IPO Year
- INTZ 2020
- CING 2021
- Fundamental
- Price
- INTZ $1.63
- CING $3.73
- Analyst Decision
- INTZ Buy
- CING Strong Buy
- Analyst Count
- INTZ 2
- CING 4
- Target Price
- INTZ $6.50
- CING $31.00
- AVG Volume (30 Days)
- INTZ 233.3K
- CING 159.5K
- Earning Date
- INTZ 10-08-2025
- CING 11-06-2025
- Dividend Yield
- INTZ N/A
- CING N/A
- EPS Growth
- INTZ N/A
- CING N/A
- EPS
- INTZ N/A
- CING N/A
- Revenue
- INTZ $6,828,000.00
- CING N/A
- Revenue This Year
- INTZ $36.75
- CING N/A
- Revenue Next Year
- INTZ $30.90
- CING N/A
- P/E Ratio
- INTZ N/A
- CING N/A
- Revenue Growth
- INTZ 25.86
- CING N/A
- 52 Week Low
- INTZ $0.35
- CING $3.02
- 52 Week High
- INTZ $7.34
- CING $7.00
- Technical
- Relative Strength Index (RSI)
- INTZ 37.51
- CING 40.89
- Support Level
- INTZ $1.66
- CING $3.61
- Resistance Level
- INTZ $1.87
- CING $4.43
- Average True Range (ATR)
- INTZ 0.10
- CING 0.27
- MACD
- INTZ -0.01
- CING -0.01
- Stochastic Oscillator
- INTZ 6.25
- CING 20.00
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.